{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:24:46Z","timestamp":1794367486211,"version":"4.9.0"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T00:00:00Z","timestamp":1314748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n            <jats:bold>Aim:\u2002<\/jats:bold> To develop genomic signatures of seven cytokines involved in the pathogenesis of rheumatic diseases such as systemic lupus erythematosus (SLE), dermatomyositis (DM), polymyositis (PM), rheumatoid arthritis (RA), or systemic scleroderma (SSc) that could potentially help identify patients likely to respond to therapies that target these individual cytokines.<\/jats:p><jats:p>\n            <jats:bold>Methods:\u2002<\/jats:bold> Over\u2010expressed transcripts in the whole blood (WB) were identified from 262 SLE, 44 DM, 33 PM, 38 SSc and 89 RA subjects and compared to 24 healthy subjects using Affymetrix arrays. Cytokine\u2010inducible gene signatures such as type I interferon (IFN), tumor necrosis factor alpha (TNF\u2010\u03b1), interleukin (IL)\u20101\u03b2, IL\u201010, IL\u201013, IL\u201017, and granulosyte\u2013macrophage colony\u2010stimulating factor (GM\u2010CSF) were assessed in the WB of these subjects to identify subpopulations showing activation of specific cytokine pathways.<\/jats:p><jats:p>\n            <jats:bold>Results:\u2002<\/jats:bold> Significant activation of the type I IFN pathway in a population of five diseases studied was universally observed. The TNF\u2010\u03b1 and IL\u20101\u03b2 pathways were activated in subgroups of PM and RA subjects, respectively, with another subgroup of RA subjects showing activation of the IL\u201013 pathway. The GM\u2010CSF pathway was activated in a subgroup of SSc subjects and the IL\u201017 pathway was activated in subgroups of all diseases except SLE.<\/jats:p><jats:p>\n            <jats:bold>Conclusions:\u2002<\/jats:bold> A novel gene expression measurement of activated cytokines in five different rheumatic diseases is presented. Characterizing the cytokine pathways most activated in specific patient subpopulations has the potential to help target the appropriate patient populations for corresponding anti\u2010cytokine therapies.<\/jats:p>","DOI":"10.1111\/j.1756-185x.2011.01654.x","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T12:00:03Z","timestamp":1314878403000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients"],"prefix":"10.1111","volume":"15","author":[{"given":"Brandon W.","family":"HIGGS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"RICHMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"FIORENTINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"GREENBERG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahija","family":"JALLAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"YAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,31]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri702"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.397"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(02)00088-6"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11226"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115843"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0909-779"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.4061\/2009\/374312"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24557"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.61"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_5_15_2","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2007"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.092759.109"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9868.00346"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15623"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.063412"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010051165"},{"key":"e_1_2_5_21_2","first-page":"S193","article-title":"Anti\u2010TNF\u2010blockade with infliximab (Remicade) in polymyositis and dermatomyositis","volume":"43","author":"Hengstman G","year":"2000","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh539"},{"key":"e_1_2_5_23_2","first-page":"213","article-title":"Interleukin\u201013 in autoimmune rheumatic diseases: relationship with the autoantibody profile","volume":"20","author":"Spadaro A","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.8.723"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90430-3"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00067"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2001.0534"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1689"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1316-7"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.11.6173"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20001"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.085431"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2010.01.004"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2008.01.001"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700669"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802206660"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00281-1"},{"key":"e_1_2_5_40_2","first-page":"94","article-title":"Enhanced expression of the receptor for granulocyte macrophage colony stimulating factor on dermal fibroblasts from scleroderma patients","volume":"29","author":"Postiglione L","year":"2002","journal-title":"J Rheumatol"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32833b475e"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2011.01654.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2011.01654.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:02:05Z","timestamp":1695495725000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2011.01654.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,31]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1756-185X.2011.01654.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2011.01654.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,31]]},"assertion":[{"value":"2011-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}